tiprankstipranks
Trending News
More News >
Noile-Immune Biotech Inc. (JP:4893)
:4893
Japanese Market

Noile-Immune Biotech Inc. (4893) Income Statement

Compare
0 Followers

Noile-Immune Biotech Inc. Income Statement

Last quarter (Q4 2024), Noile-Immune Biotech Inc.'s total revenue was ¥2.00M, a decrease of -25.21% from the same quarter last year. In Q4, Noile-Immune Biotech Inc.'s net income was ¥-177.00M. See Noile-Immune Biotech Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 7.59M¥ 316.82M¥ 625.78M¥ 100.73M¥ 97.28M
Gross Profit
¥ 7.39M¥ 314.56M¥ 618.71M¥ 77.83M¥ 94.31M
Operating Expenses
¥ 1.08B¥ 1.09B¥ 725.05M¥ 845.34M¥ 698.78M
Depreciation and Amortization
¥ 0.00¥ 0.00¥ 106.00M¥ 766.00M¥ 12.81M
EBITDA
¥ -1.07B¥ -775.39M¥ 0.00¥ 0.00¥ -591.67M
Operating Income
¥ -1.07B¥ -775.39M¥ -106.34M¥ -767.51M¥ -604.48M
Other Income/Expenses
¥ 107.15M¥ -352.20M¥ -277.86M¥ -25.10M¥ -26.50M
Pretax Income
¥ -962.03M¥ -1.13B¥ -384.20M¥ -792.62M¥ -630.97M
Net Income
¥ -964.46M¥ -1.13B¥ -386.62M¥ -795.03M¥ -636.65M
Per Share Metrics
Basic EPS
¥ -22.26¥ -27.25¥ -9.87¥ -19.33¥ -15.48
Diluted EPS
¥ -22.26¥ -27.25¥ -9.87¥ -19.33¥ -14.52
Weighted Average Shares Outstanding
43.30M 41.47M 39.17M 41.12M 41.12M
Weighted Average Shares Outstanding (Diluted)
43.30M 41.47M 39.17M 41.12M 43.86M
Currency in JPY

Noile-Immune Biotech Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis